Industry News Industry News Biologics, Biotechnology Therapies Are Focus of USP Symposium on Drug Quality StandardsDate: 09-06-2011 -- PRWeb (09/06/11)body: The U.S. Pharmacopeial Convention (USP) has announced that it will dedicate its annual scientific symposium to the important area of quality standards for biologic and biotechnology-based drugs. The symposium will be held from Oct. 3 to Oct. 6, 2011 in Seattle Washington, opening with a keynote event, entitled “How the World Regulates Biologics,” featuring Steven Kozlowski, M.D., director of the Office of Biotechnology Products in the Office of Pharmaceutical Science in the Center for Drug Evaluation and Research (CDER) at FDA. The session will be a point-counterpoint, focusing on biosimilars.URL: http://www.prweb.com/releases/2011/9/prweb8772131.htm